Hypoglycemia and Risk of Cardiovascular Disease and All-Cause Mortality in Insulin-Treated People With Type 1 and Type 2 Diabetes: A Cohort Study

被引:276
|
作者
Khunti, Kamlesh [1 ,2 ]
Davies, Melanie [1 ,2 ]
Majeed, Azeem [3 ]
Thorsted, Brian Larsen [4 ]
Wolden, Michael Lyng [4 ]
Paul, Sanjoy K. [5 ]
机构
[1] Univ Leicester, Leicester Diabet Ctr, Leicester, Leics, England
[2] Univ Leicester, Leicester Clin Trials Unit, Leicester, Leics, England
[3] Univ London Imperial Coll Sci Technol & Med, Dept Publ Hlth & Primary Care, London, England
[4] Novo Nordisk AS, Bagsvaerd, Denmark
[5] QIMR Berghofer Med Res Inst, Clin Trials & Biostat Unit, Brisbane, Qld, Australia
关键词
GLYCEMIC CONTROL; GLUCOSE CONTROL; COMPLICATIONS; VETERANS; EVENTS;
D O I
10.2337/dc14-0920
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVEHypoglycemia has been associated with an increased risk of cardiovascular (CV) events and all-cause mortality. This study assessed whether, in a nationally representative population, there is an association between hypoglycemia, the risk of CV events, and all-cause mortality among insulin-treated people with type 1 diabetes or type 2 diabetes.RESEARCH DESIGN AND METHODSThis retrospective cohort study used data from the Clinical Practice Research Datalink database and included all insulin-treated patients (30 years of age) with a diagnosis of diabetes.RESULTSIn patients who experienced hypoglycemia, hazard ratios (HRs) for CV events in people with type 1 diabetes were 1.51 (95% CI 0.83, 2.75; P = ns) and 1.61 (1.17, 2.22), respectively, for those with and without a history of CV disease (CVD) before the index date. In people with type 2 diabetes, the HRs for patients with and without a history of CVD were 1.60 (1.21, 2.12) and 1.49 (1.23, 1.82), respectively. For all-cause mortality, HRs in people with type 1 diabetes were 1.98 (1.25, 3.17), and 2.03 (1.66, 2.47), respectively, for those with and without a history of CVD. Among people with type 2 diabetes, HRs were 1.74 (1.39, 2.18) and 2.48 (2.21, 2.79), respectively, for those with and without a history of CVD. The median time (interquartile range) from first hypoglycemia event to first CV event was 1.5 years (0.5, 3.5 years) and 1.5 years (0.5, 3.0 years), respectively, for people with type 1 and type 2 diabetes.CONCLUSIONSHypoglycemia is associated with an increased risk of CV events and all-cause mortality in insulin-treated patients with diabetes. The relationship between hypoglycemia and CV outcomes and mortality exists over a long period.
引用
收藏
页码:316 / 322
页数:7
相关论文
共 50 条
  • [41] Long-term variability of glycemic markers and risk of all-cause mortality in type 2 diabetes: the Look AHEAD study
    Kaze, Arnaud D.
    Santhanam, Prasanna
    Erqou, Sebhat
    Ahima, Rexford S.
    Echouffo-Tcheugui, Justin Basile
    BMJ OPEN DIABETES RESEARCH & CARE, 2020, 8 (02)
  • [42] All-cause mortality and cardiovascular safety of basal insulin treatment in patients with type 2 diabetes mellitus: A systematic review with meta-analysis and trial sequential analysis
    Rados, Dimitris Varvaki
    Ribeiro Falcetta, Mariana Rangel
    Pinto, Lana Catani
    Leitao, Cristiane Bauermann
    Gross, Jorge Luiz
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 173
  • [43] All-Cause and Cardiovascular Mortality following Treatment with Metformin or Glyburide in Patients with Type 2 Diabetes Mellitus
    Raee, Mohammad Reza
    Nargesi, Arash Aghajani
    Heidari, Behnam
    Mansournia, Mohammad Ali
    Larry, Mehrdad
    Rabizadeh, Soghra
    Zarifkar, Mitra
    Esteghamati, Alireza
    Nakhjavani, Manouchehr
    ARCHIVES OF IRANIAN MEDICINE, 2017, 20 (03) : 141 - 146
  • [44] All-cause mortality prediction models in type 2 diabetes: applicability in the early stage of disease
    Copetti, Massimiliano
    Biancalana, Edoardo
    Fontana, Andrea
    Parolini, Federico
    Garofolo, Monia
    Lamacchia, Olga
    De Cosmo, Salvatore
    Trischitta, Vincenzo
    Solini, Anna
    ACTA DIABETOLOGICA, 2021, 58 (10) : 1425 - 1428
  • [45] Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes
    Htay, Thwe
    Soe, Kyaw
    Lopez-Perez, Arianna
    Amy HoangAnh Doan
    Romagosa, Michael A.
    Aung, KoKo
    CURRENT CARDIOLOGY REPORTS, 2019, 21 (06)
  • [46] Cardiovascular and All-Cause Mortality Risk Associated With Urinary Excretion of 8-oxoGuo, a Biomarker for RNA Oxidation, in Patients With Type 2 Diabetes: A Prospective Cohort Study
    Kjaer, Laura K.
    Cejvanovic, Vanja
    Henriksen, Trine
    Petersen, Kasper M.
    Hansen, Torben
    Pedersen, Oluf
    Christensen, Cramer K.
    Torp-Pedersen, Christian
    Gerds, Thomas A.
    Brandslund, Ivan
    Mandrup-Poulsen, Thomas
    Poulsen, Henrik E.
    DIABETES CARE, 2017, 40 (12) : 1771 - 1778
  • [47] Cardiovascular and type 2 diabetes morbidity and all-cause mortality among diverse chronic inflammatory disorders
    Dregan, Alex
    Chowienczyk, Phil
    Molokhia, Mariam
    HEART, 2017, 103 (23) : 1867 - 1873
  • [48] Effects of β-blockers on all-cause mortality in patients with type 2 diabetes and coronary heart disease
    Tsujimoto, Tetsuro
    Sugiyama, Takehiro
    Kajio, Hiroshi
    DIABETES OBESITY & METABOLISM, 2017, 19 (06) : 800 - 808
  • [49] The interactive effects of type 2 diabetes mellitus and schizophrenia on all-cause mortality: The Fremantle Diabetes Study
    Davis, Wendy Angela
    Starkstein, Sergio E.
    Bruce, David G.
    Davis, Timothy M. E.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2015, 29 (08) : 1320 - 1322
  • [50] All-Cause and Cardiovascular Mortality in Middle-Aged People With Type 2 Diabetes Compared With People Without Diabetes in a Large UK Primary Care Database
    Taylor, Kathryn S.
    Heneghan, Carl J.
    Farmer, Andrew J.
    Fuller, Alice M.
    Adler, Amanda I.
    Aronson, Jeffrey K.
    Stevens, Richard J.
    DIABETES CARE, 2013, 36 (08) : 2366 - 2371